Rna interferases and methods of use thereof
CA 2529142 C · Owner: Inouye, Masayori · Inventors: Zhang, Junjie; Zhang, Yong Long; Inouye, Masayori
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to the discovery of a novel family of enzymes designated herein as mRNA interferases that exhibit endoribonuclease activity. The novel finding of the present inventors therefore, presents new , applications for which mRNA interferase nucleic and amino acid sequences and , compositions thereof may be used to advantage. The invention also encompasses screening methods to identify compounds/agents capable of modulating mRNA interferase activity and methods for using such compounds/agents. Also provided is a kit comprising mRNA interferase nucleic and/or amino acid sequences, mRNA interferase activity compatible buffers and instruction , materials.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 14, 2004 and granted June 3, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 14, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 14, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.